NOX — Noxopharm Share News
0.000.00%
Last trade - 00:00- AU$26.30m
- AU$30.46m
- AU$2.83m
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer
Australia's Noxopharm hits two-week high on autoimmune clinical trial progress
Brief: Noxopharm Receives NSW Government Grant For UNSW Collaboration
Brief: Noxopharm Says First US Patent For Sofra Technology Platform
Australia's Noxopharm rises on successful first dose for autoimmune disease drug
Australia's Noxopharm rises on autoimmune drug trial initiation
Brief: Noxopharm Raises Almost A$2.5 Million By Disposing Shareholding In Nyrada Inc
Australia's Noxopharm surges on drug passing safety tests
Australia's Noxopharm jumps on upbeat testing results for brain cancer drug
Australia's Noxopharm climbs to near 9-month high on upbeat results from cancer study
Brief: Noxopharm Ltd Says Scaling Up Production Of Its Preclinical SOF-SKN Lupus Medication
Australia's Noxopharm posts record gain on US FDA's orphan drug designation
Brief: Noxopharm Ltd Says US FDA Grants Orphan Drug Designation For CRO-67
Brief: Noxopharm Seeks Trading Halt
Australia's Noxopharm up on promising results for pancreatic cancer drug candidate
Brief: Noxopharm To Prioritise Allocation Of Resources To Development Of Chromatm And Sofratm Program